Similarly, patients with mild-to-moderate COVID-19 also showed early IFN responses (Galani et al., 2021) (Figure 3A), and those with severe diseases and those deceased had increased and prolonged IFN expressions in the blood (Lucas et al., 2020) (Figure 3B). Here, IFNA1 is linked to COVID-19.